Farmacología y Electrofisiología Cardiovascular
![Foto de Farmacología y Electrofisiología Cardiovascular](/img/grupo.png)
![Foto de Instituto de Investigación Sanitaria Gregorio Marañón](/img/noimage_org.png)
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (10)
2022
-
Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipeline
Expert Opinion on Investigational Drugs
-
Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome
Cardiovascular research, Vol. 118, Núm. 4, pp. 1046-1060
2021
-
A rare HCN4 variant with combined sinus bradycardia, left atrial dilatation, and hypertrabeculation/left ventricular noncompaction phenotype
Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 781-789
-
Cardiovascular Medications
Sex Differences in Cardiac Diseases: Pathophysiology, Presentation, Diagnosis and Management (Elsevier), pp. 597-642
-
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448
2020
-
The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval
Scientific Reports, Vol. 10, Núm. 1
2018
-
New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors
European heart journal. Cardiovascular pharmacotherapy
2017
-
Future drug discovery in renin-angiotensin-aldosterone system intervention
Expert Opinion on Drug Discovery, Vol. 12, Núm. 8, pp. 827-848
2016
-
Vascular and central activation of peroxisome proliferator-activated receptor-β attenuates angiotensin II-induced hypertension: Role of RGS-5
Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 1, pp. 151-163
2013
-
Chronic atrial fibrillation up-regulates β1-Adrenoceptors affecting repolarizing currents and action potential duration
Cardiovascular Research, Vol. 97, Núm. 2, pp. 379-388